Voelckel W G, Lurie K G, McKnite S, Zielinski T, Lindstrom P, Peterson C, Krismer A C, Lindner K H, Wenzel V
Cardiac Arrhythmia Center, Department of Medicine, University of Minnesota 55455, USA.
Crit Care Med. 2000 Dec;28(12):3777-83. doi: 10.1097/00003246-200012000-00001.
This study was designed to compare the effects of vasopressin vs. epinephrine vs. the combination of epinephrine with vasopressin on vital organ blood flow and return of spontaneous circulation in a pediatric porcine model of asphyxial arrest.
Prospective, randomized laboratory investigation using an established porcine model for measurement of hemodynamic variables, organ blood flow, blood gases, and return of spontaneous circulation.
University hospital laboratory.
Eighteen piglets weighing 8-11 kg.
Asphyxial cardiac arrest was induced by clamping the endotracheal tube. After 8 mins of cardiac arrest and 8 mins of cardiopulmonary resuscitation, a bolus dose of either 0.8 units/kg vasopressin (n = 6), 200 microg/kg epinephrine (n = 6), or a combination of 45 microg/kg epinephrine with 0.8 units/kg vasopressin (n = 6) was administered in a randomized manner. Defibrillation was attempted 6 mins after drug administration.
Mean +/- SEM coronary perfusion pressure, before and 2 mins after drug administration, was 13 +/- 2 and 23 +/- 6 mm Hg in the vasopressin group; 14 +/- 2 and 31 +/- 4 mm Hg in the epinephrine group; and 13 +/- 1 and 33 +/- 6 mm Hg in the epinephrine-vasopressin group, respectively (p = NS). At the same time points, mean +/- SEM left ventricular myocardial blood flow was 44 +/- 31 and 44 +/- 25 mL x min-(1) x 100 g(-1) in the vasopressin group; 30 +/- 18 and 233 +/- 61 mL x min(-1) x 100 g(-1) in the epinephrine group; and 36 +/- 10 and 142 +/- 57 mL x min(-1) x 100 g(-1) in the epinephrine-vasopressin group (p < .01 epinephrine vs. vasopressin; p < .02 epinephrine-vasopressin vs. vasopressin). Total cerebral blood flow trended toward higher values after epinephrine-vasopressin (60 +/- 19 mL x min(-1) x 100 g(-1)) than after vasopressin (36 +/- 17 mL x min(-1) x 100 g(-1)) or epinephrine alone (31 +/- 7 mL x min(-1) x 100 g(-1); p = .07, respectively). One of six vasopressin, six of six epinephrine, and four of six epinephrine-vasopressin-treated animals had return of spontaneous circulation (p < .01, vasopressin vs. epinephrine).
Administration of epinephrine, either alone or in combination with vasopressin, significantly improved left ventricular myocardial blood flow during cardiopulmonary resuscitation. Return of spontaneous circulation was significantly more likely in epinephrine-treated pigs than in animals resuscitated with vasopressin alone.
本研究旨在比较血管加压素、肾上腺素以及肾上腺素与血管加压素联合使用对窒息性心脏骤停仔猪模型重要器官血流及自主循环恢复的影响。
采用已建立的仔猪模型进行前瞻性、随机实验室研究,以测量血流动力学变量、器官血流、血气及自主循环恢复情况。
大学医院实验室。
18头体重8 - 11千克的仔猪。
通过夹闭气管导管诱导窒息性心脏骤停。心脏骤停8分钟及心肺复苏8分钟后,随机给予0.8单位/千克血管加压素(n = 6)、200微克/千克肾上腺素(n = 6)或45微克/千克肾上腺素与0.8单位/千克血管加压素联合用药(n = 6)的大剂量药物。给药6分钟后尝试除颤。
血管加压素组给药前及给药后2分钟平均±标准误冠状动脉灌注压分别为13±2和23±6毫米汞柱;肾上腺素组为14±2和31±4毫米汞柱;肾上腺素 - 血管加压素组为13±1和33±6毫米汞柱(p =无显著性差异)。在相同时间点,血管加压素组平均±标准误左心室心肌血流量分别为44±31和44±25毫升·分钟⁻¹·100克⁻¹;肾上腺素组为30±18和233±61毫升·分钟⁻¹·100克⁻¹;肾上腺素 - 血管加压素组为36±10和142±57毫升·分钟⁻¹·100克⁻¹(肾上腺素与血管加压素相比p <.01;肾上腺素 - 血管加压素与血管加压素相比p <.02)。肾上腺素 - 血管加压素组(60±19毫升·分钟⁻¹·100克⁻¹)后全脑血流量趋向高于血管加压素组(36±17毫升·分钟⁻¹·100克⁻¹)或单独使用肾上腺素组(31±7毫升·分钟⁻¹·100克⁻¹;p分别为.07)。血管加压素治疗的6只动物中有1只、肾上腺素治疗的6只动物中有6只、肾上腺素 - 血管加压素治疗的6只动物中有4只恢复自主循环(血管加压素与肾上腺素相比p <.01)。
单独使用肾上腺素或肾上腺素与血管加压素联合使用在心肺复苏期间显著改善左心室心肌血流量。接受肾上腺素治疗的仔猪比单独使用血管加压素复苏的动物更有可能恢复自主循环。